Hong Kong Island, Hong Kong, China The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined VC is situated in the Hong Kong.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Lotus BioScience Ventures, startups are often financed by Sofinnova Investments, Singapore Bio-Innovations, Alloy Ventures. The meaningful sponsors for the fund in investment in the same round are Sofinnova Investments, Singapore Bio-Innovations, MPM Capital. In the next rounds fund is usually obtained by Singapore Bio-Innovations, Sofinnova Investments, Roche Venture Fund.
The higher amount of exits for fund were in 2017. This Lotus BioScience Ventures works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2005. The fund is constantly included in less than 2 deals per year. The average startup value when the investment from Lotus BioScience Ventures is 5-10 millions dollars.
The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Nereus Pharmaceuticals, Humanigen For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Medical, Biotechnology.
Related Funds
| Fund Name | Location |
| Agile Venture Capital | California, San Francisco, United States |
| Brunei Investment Agency | Bandar Seri Begawan, Brunei |
| Caymus Equity | New York, New York, United States |
| Eminence Ventures | China, Shanghai |
| Innovative Medical Management | Anaheim, California, United States |
| Langdell Investments | California, Sunnyvale, United States |
| Madison Alley Global Ventures | New York, New York, United States |
| Ningbo Meishan Baoshui Gangqu Huahan Yuyuan Guquan Touzi Hehuo Qiye (Youxian Hehuo) | China, Ningbo, Zhejiang |
| P5 Health Ventures | Connecticut, Fairfield, United States |
| Prime Venture Partners | Bengaluru, India, Karnataka |
| Shalom Equity Fund | - |
| Shanghai International Group (SIG) | China, Shanghai |
| Star Mica | Japan, Tokyo |
| Supercell | Finland, Helsinki, Southern Finland |
| Supernode | British Columbia, Canada, Vancouver |
| Untapped Capital | - |
| Xinyu Renzhi Touzi Guanli Zhongxin | China, Jiangxi, Xinyu |
| ZG Ventures | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Humanigen | $20M | 16 Mar 2005 | California, United States | ||
Infinity Pharmaceuticals | $70M | 24 Jun 2002 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Humanigen | $20M | 16 Mar 2005 | California, United States | ||
Infinity Pharmaceuticals | $70M | 24 Jun 2002 | Cambridge, Massachusetts, United States |
